Interested in Partnering or Investing?
Our mission is to improve outcomes for millions of cancer patients through safer and more effective therapies. We welcome conversations with investors, industry leaders, and collaborators interested in shaping the future of oncology.
Let’s explore how we can create long-term value together.
Inquiry Forms
Submit your details to direct clinical trial, scientific collaboration, partnership, and media requests to the appropriate Oncolipomab team.
Visit us
Rajamyllyntie 2, 01760, Vantaa, Finland
Hours
Monday–Friday, 9am–5pm
Phone
+358 (0) 449873155